Cardiff Oncology, Inc. (CRDF) › RevenueCardiff Oncology, Inc. (CRDF) — RevenueAnnual figures by period end, from SEC filings.2020-12-31: $366.0K2021-12-31: $359.0K2022-12-31: $386.0K2023-12-31: $488.0K2024-12-31: $683.0K2025-12-31: $593.0K$593.0K2020-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$593.0K-13.2%2026-02-24From 2025-01-012024-12-31$683.0K+40.0%2026-02-24From 2024-01-012023-12-31$488.0K+26.4%2025-02-27From 2023-01-012022-12-31$386.0K+7.5%2024-02-29From 2022-01-012021-12-31$359.0K-1.9%2023-03-02From 2021-01-012020-12-31$366.0K—2022-02-24From 2020-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)